Published in Scand J Infect Dis on January 01, 1987
Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime. Trans Am Ophthalmol Soc (1993) 0.88
Fatal cardiac tamponade after acupuncture through congenital sternal foramen. Lancet (1995) 3.22
Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol (2001) 2.77
The middle-Norway eye-screening study. II. Prevalence of simple and capsular glaucoma. Acta Ophthalmol (Copenh) (1991) 1.63
[Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy]. Tidsskr Nor Laegeforen (2000) 1.48
Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. Br J Cancer (2009) 1.41
[Telepathology in Mid-Norway]. Tidsskr Nor Laegeforen (1999) 1.37
Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid. J Antimicrob Chemother (1983) 1.15
Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg (1985) 1.11
Pharmacokinetics and tissue concentrations of ceftazidime in burn patients. Eur J Clin Pharmacol (1988) 1.09
Site distribution of colorectal adenocarcinomas. A retrospective study of 853 tumours. Scand J Gastroenterol (1986) 1.06
Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs (1987) 1.02
Pseudo-exfoliation and mortality. Acta Ophthalmol Scand (1997) 1.02
The Middle-Norway eye-screening study. I. Epidemiology of the pseudo-exfoliation syndrome. Acta Ophthalmol (Copenh) (1988) 0.99
Tumour site: a prognostic factor in colorectal cancer? A multivariate analysis. Scand J Gastroenterol (1987) 0.97
Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg (2003) 0.93
Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg (1987) 0.93
Barrett's esophagus after total gastrectomy. J Clin Gastroenterol (1988) 0.92
Lipomembranous osteodysplasia: a case report. Int Orthop (1983) 0.91
Characterization of immunoglobulins in Hodgkin cells. Int J Cancer (1977) 0.91
Histologic confirmation of endometriosis in different peritoneal lesions. Acta Obstet Gynecol Scand (1992) 0.87
Pseudo-exfoliation, IOP and glaucoma. Acta Ophthalmol (Copenh) (1991) 0.87
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother (1991) 0.87
Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol (1986) 0.87
Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl (1999) 0.87
Penetration of ceftazidime into the normal rabbit and human eye. Scand J Infect Dis Suppl (1985) 0.86
Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope (1997) 0.84
Homocystinuria treated with pyridoxine. Acta Ophthalmol (Copenh) (1982) 0.83
ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand J Gastroenterol (1986) 0.82
The probability of having glaucoma at different IOP levels. Acta Ophthalmol (Copenh) (1991) 0.81
Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid. J Antimicrob Chemother (1986) 0.81
Ophthalmological findings in pupils of a primary school with particular reference to reading difficulties. Acta Ophthalmol (Copenh) (1982) 0.80
Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study. Acta Ophthalmol (Copenh) (1982) 0.80
Pharmacokinetics of intraperitoneally instilled aminophylline, terbutaline and tobramycin in pigs. Acta Anaesthesiol Scand (2007) 0.80
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. Eur J Clin Pharmacol (1983) 0.79
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma. Cancer Chemother Pharmacol (1987) 0.79
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Br J Clin Pharmacol (1983) 0.78
DNA content in adenoid cystic carcinomas. Head Neck (1995) 0.78
Epithelial wound healing of the rat cornea after excimer laser ablation. Acta Ophthalmol Scand (1997) 0.78
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Cancer Chemother Pharmacol (1990) 0.78
The prevalence of pseudoexfoliation in three separate municipalities of Middle-Norway. A preliminary report. Acta Ophthalmol Suppl (1987) 0.78
The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy. Eur J Clin Pharmacol (1988) 0.77
Pharmacokinetics of thio-TEPA at two different doses. Cancer Chemother Pharmacol (1988) 0.77
Neuroendocrine differentiation in bronchial carcinomas of classic squamous-cell type: an immunohistochemical study of 29 cases applying the tyramide signal amplification technique. Appl Immunohistochem Mol Morphol (2001) 0.77
Frequency distribution of IOP. Analysis of a material using the gamma distribution. Acta Ophthalmol (Copenh) (1991) 0.77
[Inactivation of drugs by acetylation]. Tidsskr Nor Laegeforen (1975) 0.76
Outpatient anterior chamber lens implantation. Acta Ophthalmol (Copenh) (1988) 0.76
Senile cataract and ascorbic acid loading. Acta Ophthalmol (Copenh) (1985) 0.76
Menometrorrhagia in the perimenopause is associated with increased serum estradiol. Maturitas (2004) 0.76
Pharmacokinetics of ceftazidime in patients with biliary tract disease. Eur J Clin Pharmacol (1986) 0.76
Ascorbic acid determination in serum and aqueous humour by high-performance liquid chromatography. Acta Ophthalmol (Copenh) (1985) 0.76
ABO-blood groups and D-antigen in simple and capsular glaucoma. Acta Ophthalmol (Copenh) (1984) 0.76
Labetalol in the treatment of hypertension in patients with normal and impaired renal function. Acta Med Scand Suppl (1982) 0.75
The influence of antacid on the absorption of two different sustained-release formulations of theophylline. Br J Clin Pharmacol (1983) 0.75
[Detection of narcotic drugs in the urine. A 2-year case material from Health Region IV]. Tidsskr Nor Laegeforen (1984) 0.75
The influence of sustained release theophylline therapy on free fatty acids in serum. Acta Pharmacol Toxicol (Copenh) (1985) 0.75
Pharmacokinetics of verapamil and norverapamil in patients with hypertension: a comparison of oral conventional and sustained release formulations. Pharmacol Toxicol (1988) 0.75
[Comparative study of labetolol and propranolol in patients with untreated hypertension]. Tidsskr Nor Laegeforen (1981) 0.75
Long-term therapy with sustained-release theophylline. Pharmatherapeutica (1985) 0.75
Massive left ventricular endomyocardial calcification associated with apical hypertrophic cardiomyopathy. Rofo (1988) 0.75
Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study. Scand J Gastroenterol (1984) 0.75
Pharmacokinetics and distribution of diazepam and oxazepam in early pregnancy. Acta Obstet Gynecol Scand (1988) 0.75
Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity. J Chemother (1989) 0.75
Gas chromatographic assay of triethylenethiophosphoramide in serum and urine. J Chromatogr (1985) 0.75
Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function. Am J Med (1992) 0.75
The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients. J Antimicrob Chemother (1983) 0.75
Regeneration of epithelial defects in corneas previously treated with excimer laser. A study of cell kinetics in the rat corneal epithelium. Acta Ophthalmol Scand (1998) 0.75
Steady state pharmacokinetics of tiaprofenic acid in elderly patients. Arzneimittelforschung (1985) 0.75
Single and multiple dose pharmacokinetics of tenoxicam in the elderly. Eur J Clin Pharmacol (1988) 0.75
[Acetazolamide]. Tidsskr Nor Laegeforen (1990) 0.75
The pharmacokinetics and distribution of ofloxacin into the lower respiratory tract. Drugs (1995) 0.75
Meridional anisotropia in cyclofusion. Percept Psychophys (1983) 0.75
Prognostic significance of nucleolar organizer regions in adenoid cystic carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg (1997) 0.75
The concentrations of ceftazidime and thiopental in maternal plasma, placental tissue and amniotic fluid in early pregnancy. Acta Obstet Gynecol Scand (1987) 0.75
Penetration of erythromycin in respiratory tract infections. Acta Otolaryngol Suppl (1984) 0.75
[Acetazolamide]. Tidsskr Nor Laegeforen (1990) 0.75
Pulsed Doppler ultrasound for measuring blood flow velocity in the human ophthalmic circulation. Acta Ophthalmol (Copenh) (1980) 0.75
Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy. Int J Clin Pharmacol Res (1991) 0.75
Epithelial ovarian tumor in a phenotypic male. J Surg Oncol (1987) 0.75
Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination. Acta Med Scand (1986) 0.75
[Familial pheochromocytoma associated with non Hippel-Lindau disease. A family study]. Tidsskr Nor Laegeforen (1984) 0.75
[Mass screening for cancer--where do we stand?]. Tidsskr Nor Laegeforen (1991) 0.75
The frequency distribution of the glaucoma tolerance limit. Acta Ophthalmol (Copenh) (1991) 0.75
The middle-Norway eye-screening study. III. The prevalence of capsular glaucoma is influenced by blood-group antigens. Acta Ophthalmol (Copenh) (1993) 0.75
Development of the tilted vertical horopter. Percept Psychophys (1983) 0.75
Pharmacokinetics of oral cefcanel daloxate hydrochloride in healthy volunteers and patients with various degrees of impaired renal function. J Antimicrob Chemother (1994) 0.75
The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment. Nephrol Dial Transplant (1990) 0.75